非洲艾滋病抗病毒治疗项目流失率的纵向生态分析
该研究分析了2005至2010年间9个非洲国家638家机构的307144例启动抗逆转录病毒治疗患者数据,发现6个月和12个月队列流失率分别为21%和29%,且随时间或服务成熟未见下降,但多数国家流失率稳定或下降,提示项目扩展未损害质量。
要点
- 6个月和12个月队列流失率分别为21%和29%。
- 流失率未随日历时间或服务成熟而下降。
- 多数国家流失率稳定或下降,扩展未损害质量。
核心结论
- 多数国家抗逆转录病毒治疗患者流失率稳定或下降,提示项目可在不损害质量的情况下扩展,但仍需进一步降低流失。
研究设计与样本
- 对2005至2010年9个非洲国家638家机构5638个连续队列中307144例启动抗逆转录病毒治疗患者的汇总数据进行纵向生态分析,采用泊松回归评估流失趋势及相关因素。
主要发现
- 多数国家6个月和12个月流失率稳定或下降。
- 6个月流失增加与机构有更多记录在案的转诊、较少女性接受抗逆转录病毒治疗、CD4计数记录差及启动时中位CD4计数较低相关。
- 12个月流失增加见于半城市机构、有更多记录在案的转诊及CD4计数记录差的队列,而较高患者负荷与流失减少相关。
临床怎么用
- 监测6个月和12个月队列流失率可作为评估抗逆转录病毒治疗项目质量的指标。
- 关注转诊记录多、女性患者少、CD4记录差及低CD4计数启动治疗的机构或队列,以针对性减少流失。
局限性
- 研究使用汇总数据,为生态分析,可能无法推断个体水平关联。
- 流失定义限于不再在启动机构接受抗逆转录病毒治疗,可能包括转诊或死亡等未区分情况。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: As access to antiretroviral therapy (ART) in Africa has increased dramatically, concerns have been raised regarding patient attrition, an important measure of program quality. METHODS: We examined aggregate data from 307144 patients initiating ART in 5638 successive cohorts at 638 facilities in 9 African countries from 2005 to 2010, a period characterized by massive treatment expansion. Poisson regression assessed trends in 6- and 12-month cohort attrition (ie, the proportion of patients in each cohort no longer receiving ART at their initiating facility) over calendar time and as ART services matured, and identified factors associated with attrition. RESULTS: Across all 9 countries, 6- and 12-month cohort attrition was 21% and 29%, respectively, with no decrease over calendar time (6-month P = .8735; 12-month P = .5717) or as ART services matured (6-month P = .3005; 12-month P = .2277). Additionally, attrition remained stable or decreased across both measures in nearly all countries. Initiating ART in facilities with more documented transfers and fewer women on ART, and in cohorts with poor CD4 count documentation and lower median CD4 count at ART initiation was associated with increased 6-month attrition. Increased 12-month attrition was observed in semiurban facilities and those with more documented transfers, and in cohorts with poor CD4 count documentation, whereas higher patient load was associated with decreased attrition. CONCLUSIONS: Stable or decreasing trends in attrition for ART patients were observed in most countries, suggesting programs can be expanded without compromising quality. However, further reductions in attrition are needed to maximize individual and population benefits of ART.
引用
- Elul B, Saito S, Chung H, et al. Attrition From Human Immunodeficiency Virus Treatment Programs in Africa: A Longitudinal Ecological Analysis Using Data From 307 144 Patients Initiating Antiretroviral Therapy Between 2005 and 2010. Clin Infect Dis. 2017. PMID: 28329244. doi:10.1093/cid/cix162
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。